In today’s world, healthcare is at a crossroads. There is an increasing need for clinicians to generate higher clinical value and improve patient satisfaction. As a leading provider of clinical diagnosis and treatment solutions, Neusoft Medical believes in understanding the challenges and helping healthcare providers meet them.
MRI: Increasing your clinical value with unique technology
BrainQuant, an innovative technology in NeuMR 1.5T MRI, was developed in collaboration with institutes and teaching hospitals to serve advanced applications.
The BrainQuant provides at least 10 contrasts and quantitative high resolution 3D images, including routine, quantitative and angiographic imaging. That accurate information could be used for the diagnosis of tumors, stroke, and iron metabolism-related diseases, e.g. Parkinson’s disease. With AIM-based acceleration technique, it takes only around 6min, but even more than 24min in conventional way on the contrary.
T1W image can provide a good histological image, while contrast-enhanced T1-weighted eT1W has better gray and white matter contrast than conventional T1W image; T1 quantitative image can be used in the study of multiple sclerosis and other diseases.
The PDW image reflects the amount of hydrogen protons in the tissue and is used for the measurement of tissue water content; the PD quantitative image can be used to detect changes in tissue water content caused by brain tumors.
T2* image can reflect the changes of tissue iron content and oxygen content through the influence of tissue susceptibility differences on the signal and can be used in the diagnosis of neurological diseases.
BrainQuant clinical value exploration: Stroke value research; Value research in neurodegenerative diseases: Evaluation of efficacy in Alzheimer’s disease and Parkinson’s disease; Calcification and hemorrhage Identification; Tumor screening, etc.
CT: Various low-dose technologies to ensure patient safety
CT radiation dose has been the target of various recommendations, protocols, and guidelines designed to reduce doses that patients receive, especially for pediatrics.
O-dose platform is an integrated approach for dose management from Neusoft Medical. It encompasses a set of techniques, programs and practices based on ALARA (As Low As Reasonably Achievable) principle and supports outstanding image quality at low dose. It is incorporated in every aspect of scanning. It provides a full range of low dose solutions for everyone involved to preserve the image quality while delivering more care to patients and operators.
- CARE60
Unique 60kV scanning, leading ClearView Iterative Reconstruction Algorithm optimizes dose level and image quality, making scanning safer for paediatric scans, oncology and chronic diseases follow-up, delivering better results and improving standard for care. NeuViz CT exclusively offers 60kV scanning, an industry first, for better patient care. ClearView is 100% deep iteration from raw data space to image space. Compared to 120kV, CARE60 provides over 94% dose reduction with diagnostically unaffected image quality. The radiation dose is kept at a very low level, only 0.1mSv for every lung screening while
maintaining good image quality. Furthermore, it also maintains the contrast concentration
while reducing the radiation dose.
- 3D dose modulation
A real time low-dose technology is based on different patient body sizes, anatomy, tube exposure angles and scanning positions rather than protocols already set, which could lead
to inappropriate dose. It automatically recommends the optimal mAs with the lowest possible dose for guaranteed image quality.
Living our mission of “Creating value for medical institutions and enhancing global healthcare to all”, Neusoft Medical is delivering advanced, accurate, and accessible medical imaging solutions through superior technologies and patient-centred care.
- For more information, visit: http://www.neusoftmedical.com/en/
